MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
3.850
+0.290
+8.15%
After Hours: 3.400 -0.45 -11.69% 18:51 04/24 EDT
OPEN
3.680
PREV CLOSE
3.560
HIGH
3.890
LOW
3.630
VOLUME
3.58K
TURNOVER
0
52 WEEK HIGH
5.93
52 WEEK LOW
1.530
MARKET CAP
34.11M
P/E (TTM)
-5.7130
1D
5D
1M
3M
1Y
5Y
Nutriband signs exclusive supplier agreement with Fit for Life
Nutriband signs exclusive supplier agreement with Fit for Life. Nutriband's wholly owned contract manufacturing unit, Active Intelligence, will act as manufacturer for FFL's new product launch under one of their top brands. The company is a subsidiary of Fit For Life Inc.
Seeking Alpha · 1d ago
Weekly Report: what happened at NTRB last week (0415-0419)?
Weekly Report · 2d ago
Nutriband Discloses $8.4M Private Placement Representing 2.10M Shares Of Common Stock At $4 Per Share; Company Targets 505(b)(2) NDA To FDA For Marketing Approval Of AVERSA Fentanyl In Q1 2025
AVERSA Fentanyl has the potential to become the world's first opioid patch with abuse deterrent properties. The private placement is expected to close in 2024. The company says it could reach peak annual US sales of $80 million to $200 million. Company says each investor receives a five-year warrant to purchase two shares of stock.
Benzinga · 5d ago
Weekly Report: what happened at NTRB last week (0408-0412)?
Weekly Report · 04/15 12:01
Weekly Report: what happened at NTRB last week (0401-0405)?
Weekly Report · 04/08 12:08
Nutriband stock climbs on receiving first order for sports brand licensee Fit for Life Group
Nutriband stock climbs on receiving first order for sports brand licensee Fit for Life Group. Nutriband shares rise about 12% in early trading after announcing first order from Fit For Life Group, a major brand license holder. The company's shares are up about 12%.
Seeking Alpha · 04/01 14:18
Precision Biosciences, Mesoblast, Pulse Biosciences among healthcare movers
Precision Biosciences, Mesoblast, Pulse Bioscience among healthcare movers. S&P 500 Health Care Sector -0.89% to 1708.7. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index. Health Care Select Sector SPDR® Fund ETF.
Seeking Alpha · 04/01 14:00
Weekly Report: what happened at NTRB last week (0325-0329)?
Weekly Report · 04/01 12:04
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. The Company's development pipeline includes AVERSA Buprenorphine and AVERSA Methylphenidate. The Company is also developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. Its AVERSA Fentanyl is an abuse-deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse-deterrent technology to reduce the abuse and misuse of fentanyl patches. It is also exploring transdermal delivery of proteins and peptides such as exenatide for type 2 diabetes and follicle-stimulating hormone (FSH) for infertility.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.